Records containing: Performance of NT-301 Nasal Spray Device

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2026-02-19
A Phase 1, Two-Part Study of Nasal NT-301 Safety, Tolerability, and Pharmacokinetics in Healthy Volunteers: a Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Investigation Followed by an Open-Label, Two-Way, Two-Period, Crossover Evaluation of NT-301 Bioavailability Compared to Subcutaneous Apomorphine